About

I am an award-winning writer, editor, photographer and designer with more than 30 years of experience in the media. After studying at the University of Leeds, then London and Anglia HEC, I moved to Canada in the 1980s and started out on the radio while also writing for various music and sports publications, and doing freelance photography. I then edited some magazines before working at a science organization, doing communications and editing publications in a programming language called LaTeX that was challenging but exciting.

Following that, I edited a newspaper, spent some time in the US, and then moved back to the UK where I edited a food B2B publication.
I’ve written, and taken photographs for, hundreds of publications around the world, as well as for books, album covers, DVDs, and shot coverage for documentaries. I’ve edited books, written nine of my own, and done redesigns for several publications. And now I’m writing about biotech, as well as creating videos and a weekly podcast.

I’ve done other things, like running an aquarium, teaching photography and drumming (not at the same time), and running football (soccer) refereeing courses.

In what spare time I have, I love spending time with my wife, son and dog, challenging hikes up the Scottish hills (and down again), playing and writing music, watching baseball and soccer, and collecting memorabilia and autographs.

Articles by Jim Cornall

Promising drug candidate discovered for prevention of type 1 diabetes 

Avstera receives funding for cancer programs

Researchers develop new nanoparticle to deliver drugs direct to macrophages

Ascentage Pharma gets Chinese approval for solid tumor study

Novel branched lipid boosts mRNA delivery to cells

Looking for cancer clues? Copper may open new drug treatment doors

ADVERTISEMENT

New radiopharmaceutical shrinks prostate cancer tumors

Funding for NRG Therapeutics to work on mitochondria link to Parkinson’s and ALS

GHO Capital and Vistria Group to acquire CDMO Alcami

Does covid vaccination boost cancer treatment?

Google and Meta AI could boost cancer research and drug discovery

AI program yields multiple novel RSV drug targets

ADVERTISEMENT